Moving a Carbohydrate Mimetic Peptide into the clinic

References

• OnoM, HakomoriS. Glycosylation defining cancer cell motility and invasiveness. Glycoconj J2004; 20:71 - 8; http://dx.doi.org/10.1023/B:GLYC.0000018019.22070.7d; PMID: 14993838
   PubMed Web of Science ®Google Scholar
• HakomoriS. Carbohydrate-to-carbohydrate interaction, through glycosynapse, as a basis of cell recognition and membrane organization. Glycoconj J2004; 21:125 - 37; http://dx.doi.org/10.1023/B:GLYC.0000044844.95878.cf; PMID: 15483378
   PubMed Web of Science ®Google Scholar
• PashovA, Monzavi-KarbassiB, RaghavaGP, Kieber-EmmonsT. Bridging innate and adaptive antitumor immunity targeting glycans. J: 354068. Epub2010; 352010:354015
   Google Scholar
• PashovA, Monzavi-KarbassiB, Kieber-EmmonsT. Glycan mediated immune responses to tumor cells. Hum Vaccin2011; 7:Suppl156 - 65; http://dx.doi.org/10.4161/hv.7.0.14578; PMID: 21321481
   PubMed Web of Science ®Google Scholar
• AixinjueluoW, FurukawaK, ZhangQ, HamamuraK, TokudaN, YoshidaS, UedaR, FurukawaK. Mechanisms for the apoptosis of small cell lung cancer cells induced by anti-GD2 monoclonal antibodies: roles of anoikis. J Biol Chem2005; 280:29828 - 36; http://dx.doi.org/10.1074/jbc.M414041200; PMID: 15923178
   PubMed Web of Science ®Google Scholar
• KlingerM, FarhanH, JustH, DrobnyH, HimmlerG, LoibnerH, MuddeGC, FreissmuthM, SexlV. Antibodies directed against Lewis-Y antigen inhibit signaling of Lewis-Y modified ErbB receptors. Cancer Res2004; 64:1087 - 93; http://dx.doi.org/10.1158/0008-5472.CAN-03-2435; PMID: 14871842
   PubMed Web of Science ®Google Scholar
• LiuD, LiuJ, LinB, LiuS, HouR, HaoY, LiuQ, ZhangS, IwamoriM. Lewis y Regulate Cell Cycle Related Factors in Ovarian Carcinoma Cell RMG-I in Vitro via ERK and Akt Signaling Pathways. Int J Mol Sci2012; 13:828 - 39; http://dx.doi.org/10.3390/ijms13010828; PMID: 22312289
   PubMedGoogle Scholar
• AzizF, QiuY. The role of anti-LeY antibody in the downregulation of MAPKs/COX-2 pathway in gastric cancer. Curr Drug Targets2014; 15:469 - 76; http://dx.doi.org/10.2174/1389450115666140217152042; PMID: 24533777
   PubMedGoogle Scholar
• ChereshDA, PierschbacherMD, HerzigMA, MujooK. Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins. J Cell Biol1986; 102:688 - 96; http://dx.doi.org/10.1083/jcb.102.3.688; PMID: 3005335
   PubMed Web of Science ®Google Scholar
• ChenYX, ChenXW, LiCG, YueLJ, MaiHR, WenFQ. Effect of tumor gangliosides on tyrosine phosphorylation of p125FAK in platelet adhesion to collagen. Oncol Rep2013; 29:343 - 8; PMID: 23117335
   PubMed Web of Science ®Google Scholar
• Kieber-EmmonsT, LuoP, QiuJ, ChangTY, OI, Blaszczyk-ThurinM, SteplewskiZ. Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses. Nat Biotechnol1999; 17:660 - 5; http://dx.doi.org/10.1038/10870; PMID: 10404158
   PubMed Web of Science ®Google Scholar
• Monzavi-KarbassiB, ArtaudC, JousheghanyF, HenningsL, Carcel-TrullolsJ, ShaafS, KorourianS, Kieber-EmmonsT. Reduction of spontaneous metastases through induction of carbohydrate cross-reactive apoptotic antibodies. J Immunol2005; 174:7057 - 65; http://dx.doi.org/10.4049/jimmunol.174.11.7057; PMID: 15905549
   PubMed Web of Science ®Google Scholar
• Monzavi-KarbassiB, HenningsLJ, ArtaudC, LiuT, JousheghanyF, PashovA, MuraliR, HutchinsLF, Kieber-EmmonsT. Preclinical studies of carbohydrate mimetic peptide vaccines for breast cancer and melanoma. Vaccine2007; 25:3022 - 31; http://dx.doi.org/10.1016/j.vaccine.2007.01.072; PMID: 17303294
   PubMed Web of Science ®Google Scholar
• Monzavi-KarbassiB, LuoP, JousheghanyF, Torres-QuiñonesM, Cunto-AmestyG, ArtaudC, Kieber-EmmonsT. A mimic of tumor rejection antigen-associated carbohydrates mediates an antitumor cellular response. Cancer Res2004; 64:2162 - 6; http://dx.doi.org/10.1158/0008-5472.CAN-03-1532; PMID: 15026358
   PubMedGoogle Scholar
• WondimuA, ZhangT, Kieber-EmmonsT, GimottyP, SproesserK, SomasundaramR, FerroneS, TsaoCY, HerlynD. Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice. Cancer Immunol Immunother2008; 57:1079 - 89; http://dx.doi.org/10.1007/s00262-007-0439-4; PMID: 18157673
   PubMed Web of Science ®Google Scholar
• QiuJ, LuoP, WasmundK, SteplewskiZ, Kieber-EmmonsT. Towards the development of peptide mimotopes of carbohydrate antigens as cancer vaccines. Hybridoma1999; 18:103 - 12; http://dx.doi.org/10.1089/hyb.1999.18.103; PMID: 10211797
   PubMed Web of Science ®Google Scholar
• LuoP, AgadjanyanM, QiuJ, WesterinkMA, SteplewskiZ, Kieber-EmmonsT. Antigenic and immunological mimicry of peptide mimotopes of Lewis carbohydrate antigens. Mol Immunol1998; 35:865 - 79; http://dx.doi.org/10.1016/S0161-5890(98)00067-4; PMID: 9839555
   PubMedGoogle Scholar
• HenningsL, ArtaudC, JousheghanyF, Monzavi-KarbassiB, PashovA, Kieber-EmmonsT. Carbohydrate mimetic peptides augment carbohydrate-reactive immune responses in the absence of immune pathology. Cancers (Basel)2011; 3:4151 - 69; http://dx.doi.org/10.3390/cancers3044151; PMID: 24213131
   PubMedGoogle Scholar
• LloydKO. Carbohydrate vaccines for the immunotherapy of cancer. Drug News Perspect2000; 13:463 - 70; PMID: 12937618
   PubMed Web of Science ®Google Scholar
• RagupathiG, LivingstonPO, HoodC, GathuruJ, KrownSE, ChapmanPB, WolchokJD, WilliamsLJ, OldfieldRC, HwuWJ. Consistent antibody response against ganglioside GD2 induced in patients with melanoma by a GD2 lactone-keyhole limpet hemocyanin conjugate vaccine plus immunological adjuvant QS-21. Clin Cancer Res2003; 9:5214 - 20; PMID: 14614001
   PubMed Web of Science ®Google Scholar
• VollmersHP, BrändleinS. Natural antibodies and cancer. N Biotechnol2009; 25:294 - 8; http://dx.doi.org/10.1016/j.nbt.2009.03.016; PMID: 19442595
   PubMed Web of Science ®Google Scholar
• RosenbergerWF, HainesLM. Competing designs for phase I clinical trials: a review. Stat Med2002; 21:2757 - 70; http://dx.doi.org/10.1002/sim.1229; PMID: 12228889
   PubMed Web of Science ®Google Scholar